Fatty acids and sleep in depressed inpatients

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 76, Issue 1, 2007, Pages 1-7

  Irmisch, G ^a   Schlafke D ^a   Gierow, W ^a   Herpertz, S ^a   Richter, J ^b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b Center for Child and Adolescent Mental Health   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; EICOSADIENOIC ACID; FATTY ACID; LINOLEIC ACID; LONG CHAIN FATTY ACID; MYRISTIC ACID; OLEAMIDE; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PALMITOLEIC ACID; PROSTAGLANDIN D2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DEPRESSION; DISEASE SEVERITY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SLEEP; SLEEP DISORDER;

ADULT; ANALYSIS OF VARIANCE; DEPRESSIVE DISORDER; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MIDDLE AGED; SLEEP DISORDERS;

EID: 33846021322     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.09.001     Document Type: Article

References (32)

1. Doghramji K. Treatment strategies for sleep disturbance in patients with depression. J. Clin. Psychiatry 64 suppl. (2003) 24-29
2. Maes M., Smith R., Christophe A., Cosyns P., Desnyder R., and Meltzer H. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J. Affect. Disord. 38 (1996) 35-46
3. Adams P.B., Lawson S., Sanigorski A., and Sinclair A.J. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates with clinical symptoms of depression. Lipids 1 31 suppl. (1996) S157-SS61
4. Edwards R., Peet M., Shay J., and Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patient. J. Affect. Disord. 48 (1998) 149-155
5. Yehuda S., Rabinovitz S., Carasso R.L., and Mostofsky D.I. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol. Aging 23 (2002) 843-853
6. Shapiro H. Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system?. PLEFA 68 (2003) 219-224
7. Takeuchi H., Matsuo T., Tokuyama K., Shimomura Y., and Suzuki M. Diet-induced thermogenesis is lower in rats fed a lard diet than in those fed a high oleic acid safflower oil diet, a safflower oil diet or a linseed oil diet. J. Nutr. 125 (1995) 920-925
8. Irmisch G., Höppner J., Schulz M., Schläfke D., and Richter J. Repetitive transkranielle Magnetstimulation (rTMS) bei depressiven Patienten: Fettsäurekonzentrationen im Serum und Behandlungserfolg. Klin. Neuro. 33 (2002) A11
9. Helge J.W., Wu B.J., Willer M., Daugaard J.R., Storlien L.H., and Kiens B. Training affects muscle phospholipid fatty acid composition in human. J. Appl. Physiol. 2 (2001) 670-677
10. Boger D.L., Henriksen S.J., and Cravatt B.F. Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. Curr. Pharm. Des. 4 (1998) 303-314
11. Tafti M., Petit B., Chollet D., Neidhart E., de Bilbao F., Kiss J.Z., Wood P.A., and Franken P. Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep. Nat. Genet. 34 (2003) 320-325
12. Hagve T.A. Effects of unsaturated fatty acids on cell membrane functions. Scand. J. Clin. Lab. Invest. 48 (1988) 381-388
13. Severus W.E., and Ahrens B. Omega-3 fatty acids in psychiatry. Nervenarzt 71 (2000) 58-62
14. Tsukada H., Kakiuchi T., Fukumoto D., Nishiyama S., and Koga K. Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys. Brain Res. 17 (2000) 180-186
15. Li H., Liu D., and Zhang E. Effect of fish oil supplementation on fatty acid composition and neurotransmitters of growing rats. Wei Sheng Yan Jiu 30/29 (2000) 47-49
16. Saito S., Tsuda H., and Michimata T. Prostaglandin D2 and reproduction. Am. J. Reprod. Immunol. 47 (2002) 295-302
17. Onoe H. Molecular and neuroanatomical mechanisms of sleep-wakefulness regulation by prostaglandins D2 and E2. Nippon Yakurigaku Zasshi 112 (1998) 343-349
18. Ram A., Pandey H.P., Matsumura H., Kasahara-Orita K., Nakajima T., Takahata R., Satoh S., Terao A., and Hayaishi O. CSF levels of prostaglandins, especially the level of prostaglandin D2, are correlated with increasing propensity towards sleep in rats. Brain Res. 14 (1997) 81-89
19. Nicolaidis S., Gerozissis K., and Orosco M. Variations of hypothalamic and cortical prostaglandins and monoamines reveal transitions in arousal states: microdialysis study in the rat. Rev. Neurol. (Paris). 157 11 Pt 2 (2001) S26-S33
20. de la Presa Owens S., and Innis S.M. Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninrgic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets. J. Nutr. 129 (1999) 2088-2093
21. Kunz D., Mahlberg R., Muller C., Tilmann A., and Bes F. Melatonin in patients with reduced REM sleep duration: two randomized controlled trials. J. Clin Endocrinol. Metab. 89 (2004) 128-134
22. Leaden P., Barrionuevo J., and Catala A. The protection of long chain polyunsaturated fatty acids by melatonin during nonenzymatic lipid peroxidation of rat liver microsomes. J. Pineal. Res. 32 (2002) 129-134
23. Lees G., and Dougalis A. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro. Brain Res. 30 (2004) 1-14
24. Liu Y.C., and Wu S.N. Block of erg current by linoleoylamide, a sleep-inducing agent, in pituitary GH3 cells. Eur. J. Pharmacol. 458 (2003) 37-47
25. Murillo-Rodriguez E., Cabeza R., Mendez-Diaz M., Navarro L., and Prospero-Garcia O. Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. Neuroreport 12 (2001) 2131-2136
26. Fowler C.J., Jonsson K.O., and Tiger G. Fatty acid amide hydrolase. biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol. palmitoylethanolamide, and oleamide. Biochem. Pharmacol. 62 (2001) 517-526
27. Patel S., Wohlfeil E.R., Rademacher D.J., Carrier E.J., Perry L.J., Kundu A., Falck J.R., Nithipatikom K., Campbell W.B., and Hillard C.J. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br. J. Pharmacol. 139 (2003) 1005-1013
28. Irmisch G., Schläfke D., and Richter J. Relationships between fatty acids and psychophysiological parameters in depressive inpatients under experimentally. induced stress. PLEFA 74 (2006) 149-156
29. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiat. 4 (1961) 561-571
30. Ruiz-Gutierrez V., Muriana F.J., Guerrero A., Cert A.M., and Villar J. Plasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources. J. Hypertens. 14 (1996) 1483-1490
31. Baumann C., and Bassetti C. Der Neurotransmitter Hypokretin. Ein Überblick. Nervenarzt 75 (2003) 317-323
32. Nilsson P.M., Nilsson J.A., Hedblad B., and Berglund G. Sleep disturbance in association with elevated pulse rate for prediction of mortality-consequences of mental strain?. J. Intern. Med. 250 (2001) 521-529